Empowered Patient Podcast Karen Jagoda

Dr. Darrin Starkey, Director of Education at Trace Minerals Research, emphasizes the need for a wholesome, balanced diet and the challenges people face to get necessary nutrients from the food we eat. Of particular concern are the trace elements not present in processed foods.
Darrin explains, "We are typically familiar with macrominerals, calcium, magnesium, potassium, phosphorus, and sodium. But trace minerals are often overlooked and neglected because they're needed in small amounts. So, in answer to that question, they're the trace amounts of these elements that our bodies need that make up 0.01% of our makeup and yet an essential part of our health that we often don't focus on until we're in a crisis."
"But often, because of our society, we're such a reactive society today instead of being proactive. We should wait until we're in crisis before asking the questions. But often, being proactive, of being able to put and supplement these trace minerals back into our diets, is a huge point. If we look at the variety of available foods and how we can support local growers and the waters we choose to drink, we have a lot of opportunities to minimize these deficiencies. In the society in which we live, it's critical that we put these trace minerals back in on a daily basis." 
"At Trace Minerals, our niche is putting these trace minerals back into all of our products. But our foundational product is our ConcenTrace Trace Mineral drops, and that's the foundational product that most people are familiar with. We want our listeners and consumers to understand that we're trying to do our part in the delivery system of these products. Because, as you well know, trace minerals don't taste good in a pure, concentrated state. They're very strong. So, we have to learn how to dilute those. And for those with sensitive taste buds, we offer them in tablet form, capsule form, and effervescent form. We're doing our part in helping the consumer find a way to deliver these daily that makes it enjoyable."
#TraceMinerals #TraceMineralsResearch #Remineralize #Supplements #PerformanceNutrition #Hydration #Immunity #HealthandWellness #Electrolytes
traceminerals.com
Listen to the podcast here

Dr. Darrin Starkey, Director of Education at Trace Minerals Research, emphasizes the need for a wholesome, balanced diet and the challenges people face to get necessary nutrients from the food we eat. Of particular concern are the trace elements not present in processed foods.
Darrin explains, "We are typically familiar with macrominerals, calcium, magnesium, potassium, phosphorus, and sodium. But trace minerals are often overlooked and neglected because they're needed in small amounts. So, in answer to that question, they're the trace amounts of these elements that our bodies need that make up 0.01% of our makeup and yet an essential part of our health that we often don't focus on until we're in a crisis."
"But often, because of our society, we're such a reactive society today instead of being proactive. We should wait until we're in crisis before asking the questions. But often, being proactive, of being able to put and supplement these trace minerals back into our diets, is a huge point. If we look at the variety of available foods and how we can support local growers and the waters we choose to drink, we have a lot of opportunities to minimize these deficiencies. In the society in which we live, it's critical that we put these trace minerals back in on a daily basis." 
"At Trace Minerals, our niche is putting these trace minerals back into all of our products. But our foundational product is our ConcenTrace Trace Mineral drops, and that's the foundational product that most people are familiar with. We want our listeners and consumers to understand that we're trying to do our part in the delivery system of these products. Because, as you well know, trace minerals don't taste good in a pure, concentrated state. They're very strong. So, we have to learn how to dilute those. And for those with sensitive taste buds, we offer them in tablet form, capsule form, and effervescent form. We're doing our part in helping the consumer find a way to deliver these daily that makes it enjoyable."
#TraceMinerals #TraceMineralsResearch #Remineralize #Supplements #PerformanceNutrition #Hydration #Immunity #HealthandWellness #Electrolytes
traceminerals.com
Download the transcript here

Eric Mayer, CEO of New Day Diagnostics, is tapping into the trend for more user-friendly diagnostics that patients can use to test themselves for making medical decisions. While blood draw facilities and complex testing will always be a component of healthcare, as technology progresses, more at-home testing will become available. To better support patients and providers, New Day is finding less invasive ways to collect biomarker information and using AI and machine learning to refine the interpretation of test results. 
Eric explains, "The business model is very straightforward. We design and develop our suite of diagnostic products that cover cancer testing, infectious disease testing, digestive disease, and women's health. We also operate a contract research laboratory and CRO services for other diagnostics developers, whether point-of-care or over-the-counter, who want to bring those products through the FDA. We help with those studies, and we help with the clinical trials. And then, we also deploy diagnostics. We operate a clinical laboratory where we can drive patient results through the tests that we deploy and have a network of distributors and sales channels to get kitted products and kitted diagnostic tests out into the field once they're approved."
"Depending on the type of test or the type of disease we're trying to detect, there are some that are just a yes-no. It's sort of a qualitative result. Either the virus or that bacteria is or is not there. Then, there's another for measuring numerous biomarkers in a blood sample. A liquid biopsy is a great example. At New Day Diagnostics, we incorporate AI and machine learning to combine advanced mathematics and science and distill it down to what we believe is a very easy-to-understand result for that physician and for that patient to understand. That is absolutely right. It doesn't help anybody if its result is just a mishmash of numbers without any clinical usefulness for what that result represents."
#NewDayDiagnostics #Diagnostics #Cancer #InfectiousDiseases #WomensHealth #GastrointestinalDiseases #Biomarkers 
newdaydiagnostics.com
Listen to the podcast here

Eric Mayer, CEO of New Day Diagnostics, is tapping into the trend for more user-friendly diagnostics that patients can use to test themselves for making medical decisions. While blood draw facilities and complex testing will always be a component of healthcare, as technology progresses, more at-home testing will become available. To better support patients and providers, New Day is finding less invasive ways to collect biomarker information and using AI and machine learning to refine the interpretation of test results. 
Eric explains, "The business model is very straightforward. We design and develop our suite of diagnostic products that cover cancer testing, infectious disease testing, digestive disease, and women's health. We also operate a contract research laboratory and CRO services for other diagnostics developers, whether point-of-care or over-the-counter, who want to bring those products through the FDA. We help with those studies, and we help with the clinical trials. And then, we also deploy diagnostics. We operate a clinical laboratory where we can drive patient results through the tests that we deploy and have a network of distributors and sales channels to get kitted products and kitted diagnostic tests out into the field once they're approved."
"Depending on the type of test or the type of disease we're trying to detect, there are some that are just a yes-no. It's sort of a qualitative result. Either the virus or that bacteria is or is not there. Then, there's another for measuring numerous biomarkers in a blood sample. A liquid biopsy is a great example. At New Day Diagnostics, we incorporate AI and machine learning to combine advanced mathematics and science and distill it down to what we believe is a very easy-to-understand result for that physician and for that patient to understand. That is absolutely right. It doesn't help anybody if its result is just a mishmash of numbers without any clinical usefulness for what that result represents."
#NewDayDiagnostics #Diagnostics #Cancer #InfectiousDiseases #WomensHealth #GastrointestinalDiseases #Biomarkers 
newdaydiagnostics.com
Download the transcript here

Dr. Ed Chekan is certified in general surgery and is Vice President of Medical Affairs and Professional Education at Asensus Surgical, which is taking the platform of laparoscopic surgery and adding augmented intelligence technology. Laparoscopic surgery currently starts with a digital interface in a video image. Asensus is adding augmented intelligence to the video image in real-time to support the surgeon and surgical team with additional information to improve outcomes and the experience of the clinicians.
Ed explains, "We're starting with things already being done. We have a feature that is a digital measurement. This allows the surgeon, if measurement is critical to this portion of the procedure, for instance, in general surgery, we'd say five to six centimeters from the pylorus, to start a staple line in a sleeve gastrectomy. We either estimate that through different ways, or we'd have to put a tape measure inside the patient to measure that distance accurately to get that measurement. So we're doing that now digitally."
"We have a telemanipulator. Our Asensus system is currently the second telemanipulator to be approved in the US. And so, we have it in a few centers already. And that integrates into the operating room as separate arms on separate pods or platforms that can be moved around, connected to a cockpit or a console, where the surgeon sits to do the manipulating."
"Then, the video feeds feed into our Intelligent Surgical Unit or ISU, and those video images are processed and sent to the cloud. We'll store them, we could annotate them, and we can also use them to influence, in real-time, certain types of feedback based on what would be interpreted from the video image. So, someone else is watching the video. The computer is watching the video, too, to tell you things that are happening."
@AsensusSurgical #Asensus #Robotics #DigitalStrategy #Surgery #IntraoperativeClinicalIntelligence #AugmentIntelligence 
asensus.com
Listen to the podcast here

Dr. Ed Chekan is certified in general surgery and is Vice President of Medical Affairs and Professional Education at Asensus Surgical, which is taking the platform of laparoscopic surgery and adding augmented intelligence technology. Laparoscopic surgery currently starts with a digital interface in a video image. Asensus is adding augmented intelligence to the video image in real-time to support the surgeon and surgical team with additional information to improve outcomes and the experience of the clinicians.
Ed explains, "We're starting with things already being done. We have a feature that is a digital measurement. This allows the surgeon, if measurement is critical to this portion of the procedure, for instance, in general surgery, we'd say five to six centimeters from the pylorus, to start a staple line in a sleeve gastrectomy. We either estimate that through different ways, or we'd have to put a tape measure inside the patient to measure that distance accurately to get that measurement. So we're doing that now digitally."
"We have a telemanipulator. Our Asensus system is currently the second telemanipulator to be approved in the US. And so, we have it in a few centers already. And that integrates into the operating room as separate arms on separate pods or platforms that can be moved around, connected to a cockpit or a console, where the surgeon sits to do the manipulating."
"Then, the video feeds feed into our Intelligent Surgical Unit or ISU, and those video images are processed and sent to the cloud. We'll store them, we could annotate them, and we can also use them to influence, in real-time, certain types of feedback based on what would be interpreted from the video image. So, someone else is watching the video. The computer is watching the video, too, to tell you things that are happening."
@AsensusSurgical #Asensus #Robotics #DigitalStrategy #Surgery #IntraoperativeClinicalIntelligence #AugmentIntelligence 
asensus.com
Download the transcript here